化学信息:
化学名 | 4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline | |
简称 | K-115 | |
别名 |
K115 compound, Glanatec, Ripasudil |
|
中文名 | N/A | |
化学式 | C15H18FN3O2S | |
分子量 | 323.39 | |
CAS号 | 223645-67-8 | |
纯度 | 98% | |
溶剂/溶解度 |
Water<1mg/ml; DMSO4mg/ml; Ethanol<1mg/ml |
|
溶液配制 | 5mg加入1.55ml DMSO,或者每3.23mg加入1ml DMSO,配制成10mM溶液。SC6542-10mM用DMSO配制。 |
生物信息:
产品描述 | K-115, an isoquinolinesulfonamide compound, is a highly selective and potent (IC50=31nM) Rho-kinase inhibitor; is in Phase II clinical development in patients with POAG or ocular hypertension. | ||||
信号通路 | Cell Cycle; DNA Damage | ||||
靶点 | ROCK | - | - | - | - |
IC50 | 31nM | - | - | - | - |
体外研究 | K-115 had selective and potent inhibitory effects on ROCKs. In rabbits, topical instillation of K-115 significantly reduced IOP in a dose-dependent manner. Maximum IOP reduction was observed 1h after topical instillation, which was 8.55±1.09mmHg (mean±SE) from the baseline IOP at 0.5%. In monkeys, maximum IOP reduction was observed 2h after topical instillation, which was 4.36±0.32mmHg from the baseline IOP at 0.4%, and was significantly stronger than that of 0.005% latanoprost. Whole-head autoradiography showed that the radioactivity level was maximum at 15min after instillation of [(14)C]K-115 in the ipsilateral eye. NC-induced oxidative stress, including oxidation of lipids and production of ROS, was significantly attenuated by K-115. Furthermore, expression of the Nox gene family, especially Nox1, which is involved in the NC-induced ROS production pathway, was dramatically reduced by K-115. | ||||
体内研究 | N/A | ||||
临床实验 | N/A | ||||
特征 | N/A |
相关实验数据(此数据来自于公开文献,碧云天并不保证其有效性):
酶活性检测实验 | |
方法 | N/A |
细胞实验 | |
细胞系 | N/A |
浓度 | N/A |
处理时间 | N/A |
方法 | N/A |
动物实验 | |
动物模型 | N/A |
配制 | N/A |
剂量 | N/A |
给药方式 | N/A |
产品编号 | 产品名称 | 包装 |
SC6542-10mM | K-115 (ROCK抑制剂) | 10mM×0.2ml |
SC6542-5mg | K-115 (ROCK抑制剂) | 5mg |
SC6542-25mg | K-115 (ROCK抑制剂) | 25mg |
— | 说明书 | 1份 |
保存条件:
-20℃保存,至少一年有效。5mg和25mg包装也可室温保存,至少6个月有效。如果溶于非DMSO溶剂,建议分装后-80℃保存,预计6个月内有效。